170269 ⎘
Assays involving biological materials from specific organisms or of a specific nature from viruses; RNA viruses; Togaviridae; Flaviviridae; Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
Bio-Ink and Its Preparation and Application
#2ANTI-DENV3 ANTIBODIES
#3METHOD OF IMPROVING PREDICTION ACCURACY AND REDUCING FALSE NEGATIVE RATE OF SEVERE DENGUE PREDICTION IN SUBJECT
#4RECONSTITUTION AND USES OF FLAVIVlRUS EPITOPES
#5GLYCOFORM SPECIFIC NANOBODIES AND METHODS OF USE
#6THREE-DIMENSIONAL SYNTHETIC LYMPHOID ORGANS AND ORGANOIDS FOR ANTIBODY DESIGN AND TESTING
#7TRANSGLUTAMINASE SUBSTRATES FOR LABELING
#8METHODS AND KITS FOR DETERMINING THE PRESENCE AND/OR AMOUNT OF A HUMAN IGG3 ANTIBODY SPECIFIC FOR A FLAVIVIRUS ANTIGEN IN A SAMPLE
#9USE AND DETECTION METHOD OF FLAVIVIRUS PROTEIN MICROARRAY
#10METHOD FOR REVALUATING ANTIBODY-DEPENDENT ENHANCEMENT REACTION USING PSEUDOVIRUS
#11ANTIBODY MOLECULES TO DENGUE VIRUS AND USES THEREOF
#12ISOLATED MONOCLONAL ANTIBODY, ISOLATED ANTIGEN BINDING FRAGMENT THEREOF, COMPOSITION, METHOD OF ELICITING IMMUNE RESPONSE AGAINST ANTIGENIC EPITOPE OF FLAVIVIRUS IN SUBJECT, METHOD FOR DETECTING FLAVIVIRUS, POLYPEPTIDE, AND ANTIBODY-CELL CONJUGATION
#13IMMUNOFOCUS ASSAY FOR DETERMINING THE TITER OF DENGUE VIRUSES
#14MULTISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO ZIKA VIRUS EPITOPES AND USES THEREOF
#15METHODS FOR DETERMINING COMPLEMENT-FIXING ANTIBODIES
#16METHODS AND COMPOSITIONS FOR MATURE DENGUE VIRUSES AS VACCINES AND DIAGNOSTICS
#17GLYCOFORM SPECIFIC NANOBODIES AND METHODS OF USE
#18METHODS FOR CHARACTERIZING THE IMMUNE RESPONSE OF A SUBJECT TO A DENGUE VIRUS COMPOSITION
#19METHODS FOR DETERMINING COMPLEMENT-FIXING ANTIBODIES
#20SYSTEM AND METHOD FOR COLLECTION AND DISSEMINATION OF BIOLOGIC SAMPLE TEST RESULTS DATA
#21Diagnostic Tests
#22Immunoassay platform for the serological discrimination of closely related viruses
#23HUMAN ANTIBODIES THAT NEUTRALIZE ZIKA VIRUS AND METHODS OF USE THEREFOR
#24HUMAN ANTI-DENGUE ANTIBODIES AND METHODS OF USE THEREFOR
#25Immunoassay for Detecting Zika Virus Infection
#26Pathogen Detection Using A Sensor Array
#27Methods for Reducing Electrode Gap Distances in Electronic Devices and Resulting Devices Having Nanometer Electrode Gaps Via Liquid Phase Molecular Layer Deposition Technique
#28Zero Power Visible Colorimetric Pathogen Sensors
#29Micro-Balance Biosensors to Detect Whole Viruses
#30FLAVIVIRUS ARRAYS AND USE THEREOF
#31A NOVEL COMPLEX FORMED BETWEEN THE FLAVIVIRAL NON-STRUCTURAL NS1 PROTEIN AND PLASMA LIPOPROTEINS
#32Method for detecting flavivirus-specific antibodies utilizing flaviviral NS1 polypeptides comprising the wing domain
#33Method of detecting antibodies against JEV or ZIKV using recombinant baculoviruses expressing prM/e
#34A METHOD OF IDENTIFYING A FLAVIVIRUS INFECTION, AND RELATED PEPTIDES, KITS AND COMPOSITIONS
#35Antibody molecules to dengue virus and uses thereof
#36DENGUE VIRUS NON-STRUCTURAL PROTEIN 1 SPECIFIC BINDING POLYPEPTIDES AND METHODS OF USING THE SAME
#37IMMUNOCHROMATOGRAPHY ANALYSIS DEVICE FOR DETECTING DENGUE VIRUS
#38HUMAN ANTIBODIES TARGETING ZIKA VIRUS NS1, NS1 POLYPEPTIDES AND USES THEREOF
#39SYSTEM AND METHOD FOR DIGITAL REMOTE PRIMARY, SECONDARY, AND TERTIARY COLOR CALIBRATION VIA SMART DEVICE IN ANALYSIS OF MEDICAL TEST RESULTS
#40NS1-binding protein
#41Human zika virus antibodies and methods of use therefor
#42Antibodies that bind to dengue virus serotype 4 (DENV4) and methods of making and using the same
#43LABORATORY TEST KIT AND METHOD FOR USING THE LABORATORY TEST KIT
#44Antibodies to zika virus and methods of use thereof
#45Binding protein of NS1 protein
#46NS1-Binding Protein and Uses Thereof
#47A VIRUS NEUTRALIZATION ASSAY UTILIZING IMAGING CYTOMETRY
#48Whole Virus Quantum Mechanical Tunneling Current and Electronic Sensors
#49Passive insect surveillance sensor device
#50MULTIANALYTE IMMUNOASSAY AND USES THEREOF
#51Antibodies against dengue virus and related methods
#52Methods and compositions for the detection of infections
#53Whole virus quantum mechanical tunneling current and electronic sensors
#54Chimeric insect-specific flaviviruses
#55POINT OF-CARE DIAGNOSTICS BASED ON A CHANGE IN PARTICLE MOTION BEHAVIOR
#56Immunoassay for the diagnosis of viral infections
#57diagnostic assay
#58Detection device for bioluminescent detection of biomarkers from a biological fluid sample using luminescent sensing proteins
#59Assay for the diagnosis of viral infections
#60NS2B AS MARKER FOR ZIKA VIRUS INFECTIONS
#61Multispecific antibodies specifically binding to Zika virus epitopes
#62RECOMBINANT BACULOVIRUSES AND THEIR USES IN DETECTING ARTHROPOD-BORNE VIRUS
#63ANTI-DENGUE VIRUS ANTIBODIES AND USES THEREOF
#64Measurement of afucosylated IgG Fc glycans and related vaccination methods
#65METHODS AND COMPOSITIONS FOR RECOMBINANT DENGUE VIRUSES FOR VACCINE AND DIAGNOSTIC DEVELOPMENT
#66Glycosylated analogues of Flavivirus E proteins and their use in diagnostic methods
#67Methods and systems for diagnosis and treatment of viral infections
#68Soluble and immunoreactive flaviviral NS1 polypeptides comprising the wing domain
#69Soluble and immunoreactive Zika virus NS1 polypeptides comprising the wing domain
#70Epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses
#71Immunoassay for detecting Zika virus infection
#72System and method for digital remote primary, secondary, and tertiary color calibration via smart device in analysis of medical test results
#73Immunoassay for the diagnosis of viral infections
#74System and method for remote colorimetry and ratiometric comparison and quantification in analysis of medical test results
#75Anti-dengue virus antibodies and applications thereof
#76TRAIL-BASED ENCEPHALITIS DIFFERENTIATION DIAGNOSIS METHOD AND THE APPARATUS FOR THE SAME
#77Serological assay for the detection of zika virus-specific antibodies utilizing overlapping peptides comprising an NS2B epitope
#78DEVICE AND METHOD TO DETERMINE OR QUANTIFY THE PRESENCE OF AN ANALYTE MOLECULE
#79ZIKA VIRUS ANTIBODIES
#80Modified flavivirus envelope sequences comprising unique glycosylation sites
#81Method for detecting a dengue infection
#82Human Zika virus antibodies and methods of use therefor
#83Recombinant baculoviruses and their uses in detecting arthropod-borne virus
#84Method for the immunological diagnosis of a sample with a potential infection with an arbovirus and test kits suitable for this purpose
#85Method for the detection of an IgM antibody specific for a flavivirus in a sample
#86Antibody molecules to dengue virus and uses thereof
#87Reverse genetics system of Zika virus
#88Multiplexed Immunoassay for Detecting Biomarkers of Disease
#89Vaccines against Zika virus based on Zika structure proteins
#90Methods and compositions for dengue virus vaccines and diagnostics
#91ANTI-DENGUE VIRUS ANTIBODIES AND USES THEREOF
#92RAPID IMMUNOCHROMATOGRAPHIC LATERAL FLOW ASSAY FOR EARLY ZIKA DISEASE DETECTION
#93Passive insect surveillance sensor device
#94Method and kit for determining the probability that a patient will develop a severe case of dengue
#95Method and kit for determining the probability that a patient will develop a severe case of dengue
#96MICROFLUIDIC DEVICES AND METHODS FOR PATHOGEN DETECTION IN LIQUID SAMPLES
#97Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions
#98Method for the in vitro prediction of the probability of a patient developing severe dengue, based on a blood sample
#99System and method for variable function mobile application for providing medical test results
#100System and method for image analysis of medical test results
#101System and method for collection and dissemination of biologic sample test results data
#102System and method for variable function mobile application for providing medical test results using visual indicia to determine medical test function type
#103MICROFLUIDIC DEVICES AND METHODS FOR PATHOGEN DETECTION IN LIQUID SAMPLES
#104Serotype cross-reactive, dengue neutralizing antibody and uses thereof
#105Rapid zika virus detection using nano-enabled electrochemical sensing system
#106Multiplex immuno screening assay
#107Epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses
#108Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
#109Multiplex immuno screening assay
#110Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development
#111Compositions and cell-based methods for monitoring the activity of a Dengue Virus protease
#112Dnazyme-nanoparticle conjugates and methods of use thereof
#113Test strip assembly comprising sample sorbent strip, flow separator, and reagent sorbent strip stacked on each other
#114Multiplex immuno screening assay
#115Spectrophotometer based on optical caustics
#116APTAMERS FOR BINDING FLAVIVIRUS PROTEINS
#117Drug target and construct for Japanese encephalitis virus infection
#118DNAzyme-nanoparticle conjugates and methods of use thereof
#119BIOTINYLATED PROTEIN
#120METHODS OF DETERMINING SEROTYPE SPECIFICITY OF AN ANTIBODY
#121Recombinant classical swine fever virus (CSFV) comprising substitution in the TAV epitope of the E2 protein
#122Anti-dengue virus antibodies and uses thereof
#123Distinguishing flavivirus infection using a recombinant mutant envelope protein
#124Methods and materials for the detection of dengue virus infection
#125Method and kit for determining the probability that a patient will develop a severe case of dengue
#126Method and kit for determining the probability that a patient will develop a severe case of dengue
#127Methods and compositions of non-enzymatic amplification and direct detection of nucleic acids
#128Antibody molecules to dengue virus and uses thereof
#129Bimolecular protease-based biosensor
#130Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use
#131Compositions and methods for identifying enzyme and transport protein inhibitors
#132Antibody molecules to dengue virus and uses thereof
#133Method and biomarkers for the detection of dengue hemorrhagic fever
#134DETECTION OF VIRAL DISEASES USING A BIOCHIP THAT CONTAINS GOLD NANOPARTICLES
#135Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions
#136Method for the detection of an albumin isoform
#137Devices for Automated Sample Collection, Quantificatoin, and Detection for Insect Borne Bio-Agent Surveillance
#138Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use
#139Antibody molecules to dengue virus and uses thereof
#140Cross-reactive antibodies against dengue virus and uses thereof
#141Method for the in vitro prediction of the probability of a patient developing severe dengue, based on a blood sample
#142Multiplex immuno screening assay
#143Methods and materials for the detection of dengue virus infection
#144Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
#145Inactivated chikungunya viruses (CHIKV) comprising an E1-K211E mutation
#146Process for the detection and early serotyping of the dengue virus
#147Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use
#148Methods and materials for the detection of dengue virus infection
#149Physicochemical (PCP) based consensus sequences and uses thereof
#150COMPOSITIONS AND METHODS FOR IDENTIFYING DENGUE VIRUS
#151Methods and biomarkers for the detection of dengue hemorrhagic fever
#152Compositions and methods for identifying response targets and treating flavivirus infection responses
#153Screening strategies for the identification of binders
#154Compositions and methods for identifying enzyme and transport protein inhibitors
#155BIOMARKERS FOR DENGUE
#156Anti-dengue virus antibodies
#157Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use
#158Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (JEV) and their use
#159Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
#160DENGUE DIAGNOSIS AND TREATMENT
#161NONSTRUCTURAL PROTEIN NS1 AS A NOVEL THERAPEUTIC TARGET AGAINST FLAVIVIRUSES
#162Consensus dengue virus envelope protein domain III polypeptides (cED III) and their methods of use
#163Compositions and methods for identifying response targets and treating flavivirus infection responses
#164Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use
#165Sensor platform based on toroidal resonances for rapid detection of biomolecules